粪便免疫化学检测阳性人群结肠镜后结直肠癌:患病率、预测因素与根因分析
本研究基于美国退伍军人事务部全国数据库,回顾性分析2015年1月至2022年7月接受结肠镜检查的粪便免疫化学检测(FIT)阳性患者,评估结肠镜后结直肠癌(PCCRC)的预测因素、3年PCCRC率并进行根因分析。在52,167例FIT阳性个体中识别出132例PCCRC,PCCRC-3y率为6.4%(95%CI 5.0%-7.7%)。漏诊病变和息肉切除不全是关键原因,独立预测因素包括年龄70-79岁、≥80岁、管状绒毛状腺瘤及伴高级别异型增生的腺瘤。
要点
- FIT阳性人群PCCRC-3y率为6.4%,漏诊病变与不完全切除是主因。
- 年龄70-79岁及≥80岁、管状绒毛状腺瘤、高级别异型增生腺瘤为独立预测因素。
- 16.7%的PCCRC患者指数结肠镜肠道准备差,14.4%监测间隔未遵循指南。
核心结论
- FIT阳性个体中PCCRC-3y率为6.4%,漏诊病变和不完全息肉切除是主要原因。
研究设计与样本
- 回顾性 cohort 研究,数据来自退伍军人事务部全国数据库,纳入2015年1月至2022年7月接受结肠镜检查的FIT阳性患者。
- PCCRC定义为结肠镜检查后≥6个月检测到的结直肠癌,采用世界内镜组织方法进行根因分析和计算PCCRC-3y率。
主要发现
- 在52,167例FIT阳性个体中识别出132例PCCRC,PCCRC-3y率为6.4%(95%CI 5.0%-7.7%)。
- PCCRC部位:近端结肠43.2%,远端结肠34.8%,直肠22%。
- 根因:可能新发癌17.4%,充分检查下漏诊病变31.2%,不充分检查下漏诊病变9.8%,息肉切除不完全22%,发现但未切除病变19.7%。
- 16.7%的PCCRC患者指数结肠镜肠道准备差,盲肠插管率88.6%,直肠反转率84.5%,14.4%的监测间隔未遵循指南。
- 独立预测因素:年龄70-79岁(HR 7.86;95%CI 1.08-57.39),年龄≥80岁(HR 10.18;95%CI 1.06-97.98),管状绒毛状腺瘤(HR 3.98;95%CI 2.52-6.29),伴高级别异型增生的腺瘤(HR 10.15;95%CI 5.91-17.42)。
临床怎么用
- 在FIT阳性人群的结肠镜筛查中,应关注肠道准备质量、盲肠插管和直肠反转等质量指标。
- 对高龄、管状绒毛状腺瘤或高级别异型增生腺瘤患者,应加强监测和随访。
- 确保息肉完全切除并遵循指南推荐的监测间隔,以减少PCCRC发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Postcolonoscopy colorectal cancer (PCCRC) represents an important real-world colonoscopy quality indicator. Using a national database, we evaluated predictors of PCCRC in fecal immunochemical test (FIT)-positive individuals, determined the PCCRC 3-year (PCCRC-3y) rate, and performed a root cause analysis (RCA). METHODS: This retrospective cohort study evaluated FIT-positive patients who underwent colonoscopy from January 2015 to July 2022. Data were collected from the Veterans Affairs national database. PCCRC was defined as CRC detected ≥6 months after colonoscopy. CRC was identified using Systematized Nomenclature of Medicine codes and the Veterans Affairs Cancer Registry. The World Endoscopy Organization methodology was used to perform the RCA and calculate the PCCRC-3y rate. RESULTS: We identified 132 PCCRCs among 52,167 FIT-positive individuals. The PCCRC-3y rate was 6.4% (95% confidence interval [CI] 5.0%-7.7%). PCCRC locations were proximal colon (43.2%), distal colon (34.8%), and rectum (22%). Root causes were likely new CRC (17.4%), missed lesions with adequate (31.2%) or inadequate (9.8%) examination, incomplete polyp resection (22%), and detected but unresected lesions (19.7%). 16.7% of patients with PCCRC had poor bowel preparation on index colonoscopy. The cecal intubation rate was 88.6%, and rectal retroflexion rate was 84.5%. In 14.4% of cases, recommended surveillance intervals did not adhere to established guidelines. Independent predictors of PCCRC were ages 70-79 years (hazard ratio [HR] 7.86; 95% CI 1.08-57.39), age ≥80 years (HR 10.18; 95% CI 1.06-97.98), tubulovillous adenoma (HR 3.98; 95% CI 2.52-6.29), and adenoma with high-grade dysplasia (HR 10.15; 95% CI 5.91-17.42). DISCUSSION: Among FIT-positive individuals, the PCCRC-3y rate was 6.4%, with missed lesions and incomplete resection as key contributors. These findings provide useful information on quality metrics in FIT-based CRC-screening programs.
引用
- Wilson N, Bilal M, Westanmo A, et al. Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Positive Individuals: Prevalence, Predictors, and Root Cause Analysis in a Nationwide Cohort. Am J Gastroenterol. 2025. PMID: 40622402. doi:10.14309/ajg.0000000000003635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。